VuComp announced the successful completion of the development of structured reporting (SR) for computer-aided detection (CAD) marks for digital breast tomosynthesis images.
The U.S. Food and Drug Administration (FDA) issued an approval letter in may for the Planmed Verity CBCT (cone beam computed tomography) scanner’s MaxScan maxillofacial imaging option. Planmed Verity is designed for imaging of anatomies within upper and lower extremities, as well as the maxillofacial region. The system utilizes CBCT technology with a flat panel detector, which provides high-resolution volumetric images. It is a compact, stand-alone unit from which all stages of the imaging process can be performed. Planmed Verity’s MaxScan imaging option enables flexible CBCT imaging of the regions encompassing the jaw and face.
Governor Jack Markell has just signed Delaware's Breast Density Notification Act (SB 37) into law. Delaware becomes the 23rd state to enact such legislation. The law becomes effective 180 days after the Governor's signature.
A nationwide study published in the Journal of the American College of Cardiology identified current frequent barriers to cardio-oncology services in the United States. According to the study, many hospital training programs have no formal training or services in cardio-oncology, and a lack of national guidelines and funding also creates barriers.
If you enjoy this content, please share it with a colleague
PHS Technologies Group LLC, a division of PACSHealth LLC, announced that Radiology Partners, the largest hospital-based radiology group in the United States, will begin offering PHS’s DoseMonitor to monitor patient radiation exposure.
Siemens' PETNET Solutions, a wholly owned subsidiary of Siemens Healthcare, announced it will provide clinical researchers in the greater New York City area with access to gallium-68-labeled prostate-specific membrane antigen (Ga-68 labeled PSMA). This investigational tracer is being studied for prostate cancer imaging using positron emission tomography/computed tomography (PET/CT) in clinical trials throughout the world.
aycan announced the launch of their new mammography workstation optimized for use with Eizo monitors, including the new widescreen Eizo RX850. The U.S. Food and Drug Administration (FDA) 510(k)-cleared, Apple-based workstation also includes a new Quadrant Zoom feature and tomosynthesis support that provide improved diagnostic capability.
Most women with early-stage breast cancer will undergo imaging to determine if the cancer has metastasized, despite international guidelines that recommend against testing, found a study in Canadian Medical Association Journal (CMAJ).
If you enjoy this content, please share it with a colleague
People who have nonsolid lung nodules can be safely monitored with annual low-dose computed tomography (CT) screening, according to a new study published online in the journal Radiology. Researchers said the findings could help spare patients from unnecessary surgery and additional imaging.
If you enjoy this content, please share it with a colleague
